US 7205334
Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof
granted A61PA61P13/00A61P15/08
Quick answer
US patent 7205334 (Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof) held by THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P13/00, A61P15/08, A61P19/08, A61P19/10